Physician profile
Michelle E Webster
NPI 1598717357
$6,760.77
in general payments reported to CMS, 2019-2025
36 companies · $773 in 2025
The $773 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $966 · 2021: $938 · 2022: $869 · 2023: $1,269 · 2024: $799 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,841.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,540.30 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Novo Nordisk INC | $727.76 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $534.66 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $507.59 | 2019-2025 | Trintellix |
| Astellas Pharma US INC | $471.54 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $288.21 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $281.12 | 2019-2024 | |
| Allergan, INC. | $269.61 | 2019-2020 | |
| Daiichi Sankyo INC. | $225.12 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $199.58 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $183.92 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $161.72 | 2022-2024 | |
| Eisai INC. | $143.12 | 2019-2021 | |
| Minerva Surgical, INC | $123.62 | 2023 | |
| Lupin INC. | $115.80 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $115.02 | 2023 | Azstarys |
| Therapeuticsmd, INC. | $104.57 | 2019-2021 | |
| Exact Sciences Corporation | $104.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $73.34 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $65.48 | 2021-2022 | |
| Avion Pharmaceuticals | $62.96 | 2021-2023 | NP Thyroid 60 |
| Evofem Biosciences, INC. | $57.83 | 2021 | |
| Mission Pharmacal Company | $50.24 | 2019-2020 | |
| Amgen INC. | $41.15 | 2020 | |
| Amag Pharmaceuticals, INC. | $38.73 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $36.89 | 2019 | |
| Exeltis, USA INC. | $35.61 | 2021-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $32.52 | 2020-2022 | |
| Alfasigma USA, INC. | $27.74 | 2020 | |
| Currax Pharmaceuticals LLC | $25.96 | 2020-2023 | Onzetra Xsail, Contrave |
| Kowa Pharmaceuticals America, INC. | $25.03 | 2023 | Seglentis |
| Ascend Therapeutics US, LLC | $21.12 | 2020 | |
| Glaxosmithkline, LLC. | $20.01 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Duchesnay USA Incorporated | $16.75 | 2019 | |
| Shire North American Group INC | $16.09 | 2019 | |
| Shield Therapeutics INC | $15.58 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Webster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.